There are 2934 resources available
Stage III colorectal cancer: Duration of therapy, molecular profiling
Presenter: George Zarkavelis
Session: ESMO Clinical Practice Guidelines 1
Resources:
Slides
Webcast
Stage III colorectal cancer - Discussion
Presenter: Guillem Argiles Martinez
Session: ESMO Clinical Practice Guidelines 1
Resources:
Slides
Webcast
3635 - Perioperative Chemotherapy of Oxaliplatin Combined with S-1 (SOX) versus Postoperative Chemotherapy of SOX or Oxaliplatin with Capecitabine (XELOX) in Locally Advanced Gastric Adenocarcinoma with D2 Gastrectomy: a Randomized Phase III Trial (RESOLVE Trial)
Presenter: Jiafu Ji
Session: Proffered Paper 2 – Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Proffered Paper 2 – Gastrointestinal tumours, non-colorectal - Invited Discussant LBA41 and LBA42
Presenter: Salah-Eddin Al-Batran
Session: Proffered Paper 2 – Gastrointestinal tumours, non-colorectal
Resources:
Slides
Webcast
4088 - Randomized phase 3 ANGEL study of rivoceranib (apatinib) + best supportive care (BSC) vs placebo + BSC in patients with advanced/metastatic gastric cancer who failed _2 prior chemotherapy regimens
Presenter: Yoon-Koo Kang
Session: Proffered Paper 2 – Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
Webcast
6259 - Pembrolizumab With or Without Chemotherapy vs Chemotherapy in Patients With Advanced G/GEJ Cancer (GC) Including Outcomes According to Microsatellite Instability-High (MSI-H) Status in KEYNOTE-062
Presenter: Kohei Shitara
Session: Proffered Paper 2 – Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Getting to grips with the biology of TNBC
Presenter: Carsten Denkert
Session: Tackling the diversity of triple negative early breast cancer (TNBC)
Resources:
Slides
Webcast
Neoadjuvant vs adjuvant approaches in early TNBC
Presenter: Javier Cortés
Session: Tackling the diversity of triple negative early breast cancer (TNBC)
Resources:
Slides
Webcast
DNA damaging agents and PARP inhibitors
Presenter: Veronique Dieras
Session: Tackling the diversity of triple negative early breast cancer (TNBC)
Resources:
Slides
Webcast
Future directions in TNBC early breast cancer trials
Presenter: Sibylle Loibl
Session: Tackling the diversity of triple negative early breast cancer (TNBC)
Resources:
Slides
Webcast